Council for Innovation Promotion

Publish Date
Public Comments
C4IP Comments RE: The Section 301 Investigation of Vietnam’s Acts, Policies, and Practices Related to Intellectual Property Protection (USTR-2026-0364)
Infographics & Fact Sheets
Why Congress Should Pass PERA
Public Comments
C4IP Comments RE: The Section 301 Investigation of Brazil’s Acts, Policies, and Practices Related to Intellectual Property Protection (USTR-2026-0331)
Letters
C4IP Letter to House Judiciary Subcommittee on Courts, Intellectual Property, Artificial Intelligence, and the Internet RE: Hearing on IP and the Internet
People are fed up, and Trump needs affordability win. Here’s his chance

In a recent Washington Examiner op-ed, C4IP Board Member and former U.S. Congressman Lamar Smith argues that strengthening America’s patent system can...

Washington Examiner
Senate Finance Committee Hears from ITC Nominees
IPWatchdog
Letters
C4IP Letter to Senate Finance Committee RE: Nomination of Peter-Anthony Pappas to the U.S. International Trade Commission
Fact Check: Setting the Record Straight on PTAB Reform

The U.S. Patent and Trademark Office is considering reforms to address longstanding concerns about abuse of the Patent Trial and Appeal Board...

Senate Finance Committee to Hold Nomination Hearing on Pappas’ USITC Appointment
IPWatchdog
Council for Innovation Promotion Applauds Senate Judiciary Committee Advancement of the NO FAKES Act

WASHINGTON (June 18, 2026) — Today, the Senate Judiciary Committee voted to advance the bipartisan Nurture Originals, Foster Art, and Keep Entertainment...

Intellectual property supports the U.S. economy. It should be respected abroad.

In a recent Washington Post opinion piece, C4IP Co-Chair and former USPTO Director David Kappos and former Deputy U.S. Trade Representative Jeffrey...

The Washington Post
Council for Innovation Promotion Urges Senate Judiciary Committee To Advance NO FAKES Act

WASHINGTON (June 16, 2026) — On June 18, the Senate Judiciary Committee will vote on whether to advance the bipartisan Nurture Originals,...

Op-Eds:

Op-Eds:

Can We Please Get Serious About Patents and Drug Pricing?,

01/06/2022

Op-Eds:

Op-Eds:

World leaders should acknowledge that IP protections facilitate vaccine access,

12/24/2021

Resources:

Resources:

USIJ White Paper on Fintiv Doctrine,

11/29/2021

Op-Eds:

Op-Eds:

Why does the FDA want to stop improving medicines via patent ‘areas of concern’?,

11/08/2021

Op-Eds:

Op-Eds:

Time to Fight Back Against Big Tech’s IP Assault,

10/25/2021

Op-Eds:

Op-Eds:

Biden is trying to undermine America’s world-leading IP protections,

08/11/2021

Op-Eds:

Op-Eds:

Federal Tech, Trade Bill Needs IP Owner Transparency Tweaks,

06/30/2021

Op-Eds:

Op-Eds:

Waiving Covid-19 vaccine patents won’t get shots in arms faster. It slows down new vaccines.,

05/25/2021

Op-Eds:

Op-Eds:

No evidence that patents slow access to vaccines,

04/13/2021

Resources:

Resources:

Final Report, National Security Commission on Artificial Intelligence,

03/31/2021

Resources:

Resources:

The Constitutional Protection of Intellectual Property,

03/08/2021

Resources:

Resources:

Patents and the Wealth of Nations,

05/09/2016

Scroll to Top